| Name | Title | Contact Details |
|---|
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
American Transplant Foundation is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EBD Group, Inc. is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Were on a mission to make a more pleasant world, one dose at a time. We provide natural, affordable, and effective CBD supplements to give everyone access to a happier, healthier, and more peaceful state of mind and body. Free 2-Day shipping, Lab Test...
Cyntellect is dedicated to setting new standards in cell analysis, purification, and processing technology.